These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

993 related articles for article (PubMed ID: 19470388)

  • 21. Induction of oral immune regulation towards liver-extracted proteins for treatment of chronic HBV and HCV hepatitis: results of a phase I clinical trial.
    Israeli E; Safadi R; Melhem A; Pappo O; Shibolet O; Klein A; Hemed N; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
    Liver Int; 2004 Aug; 24(4):295-307. PubMed ID: 15287852
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of influenza A infection on umbilical cord blood natural killer function regulation with interleukin-15.
    Lin SJ; Cheng PJ; Lin TY; Lee PT; Hsiao HS; Kuo ML
    J Infect Dis; 2012 Mar; 205(5):745-56. PubMed ID: 22262794
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Natural killer cells in viral hepatitis: facts and controversies.
    Mondelli MU; Varchetta S; Oliviero B
    Eur J Clin Invest; 2010 Sep; 40(9):851-63. PubMed ID: 20597961
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decreased NK cell frequency in chronic hepatitis C does not affect ex vivo cytolytic killing.
    Morishima C; Paschal DM; Wang CC; Yoshihara CS; Wood BL; Yeo AE; Emerson SS; Shuhart MC; Gretch DR
    Hepatology; 2006 Mar; 43(3):573-80. PubMed ID: 16496327
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CMV drives clonal expansion of NKG2C+ NK cells expressing self-specific KIRs in chronic hepatitis patients.
    Béziat V; Dalgard O; Asselah T; Halfon P; Bedossa P; Boudifa A; Hervier B; Theodorou I; Martinot M; Debré P; Björkström NK; Malmberg KJ; Marcellin P; Vieillard V
    Eur J Immunol; 2012 Feb; 42(2):447-57. PubMed ID: 22105371
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibitory molecules that regulate expansion and restoration of HCV-specific CD4+ T cells in patients with chronic infection.
    Raziorrouh B; Ulsenheimer A; Schraut W; Heeg M; Kurktschiev P; Zachoval R; Jung MC; Thimme R; Neumann-Haefelin C; Horster S; Wächtler M; Spannagl M; Haas J; Diepolder HM; Grüner NH
    Gastroenterology; 2011 Oct; 141(4):1422-31, 1431.e1-6. PubMed ID: 21763239
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural killer cells: primary target for hepatitis C virus immune evasion strategies?
    Golden-Mason L; Rosen HR
    Liver Transpl; 2006 Mar; 12(3):363-72. PubMed ID: 16498647
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Downregulation and altered function of natural killer cells in hepatitis B virus patients treated with entecavir.
    Zhao PW; Jia FY; Shan YX; Ji HF; Feng JY; Niu JQ; Ayana DA; Jiang YF
    Clin Exp Pharmacol Physiol; 2013 Mar; 40(3):190-6. PubMed ID: 23278368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners.
    Radaeva S; Sun R; Jaruga B; Nguyen VT; Tian Z; Gao B
    Gastroenterology; 2006 Feb; 130(2):435-52. PubMed ID: 16472598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Natural killer cell alterations correlate with loss of renal function and dialysis duration in uraemic patients.
    Vacher-Coponat H; Brunet C; Lyonnet L; Bonnet E; Loundou A; Sampol J; Moal V; Dussol B; Brunet P; Berland Y; Dignat-George F; Paul P
    Nephrol Dial Transplant; 2008 Apr; 23(4):1406-14. PubMed ID: 18029366
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fine characterization of intrahepatic NK cells expressing natural killer receptors in chronic hepatitis B and C.
    Bonorino P; Ramzan M; Camous X; Dufeu-Duchesne T; Thélu MA; Sturm N; Dariz A; Guillermet C; Pernollet M; Zarski JP; Marche PN; Leroy V; Jouvin-Marche E
    J Hepatol; 2009 Sep; 51(3):458-67. PubMed ID: 19596474
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The expression of human natural killer cell receptors in early life.
    Sundström Y; Nilsson C; Lilja G; Kärre K; Troye-Blomberg M; Berg L
    Scand J Immunol; 2007; 66(2-3):335-44. PubMed ID: 17635811
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High expression of NKG2A/CD94 and low expression of granzyme B are associated with reduced cord blood NK cell activity.
    Wang Y; Xu H; Zheng X; Wei H; Sun R; Tian Z
    Cell Mol Immunol; 2007 Oct; 4(5):377-82. PubMed ID: 17976318
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Natural killer and activated killer activities in chronic liver disease and hepatocellular carcinoma: evidence for a decreased lymphokine-induced activity of effector cells.
    Hirofuji H; Kakumu S; Fuji A; Ohtani Y; Murase K; Tahara H
    Clin Exp Immunol; 1987 May; 68(2):348-56. PubMed ID: 2820634
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Imbalanced intrahepatic cytokine expression of interferon-gamma, tumor necrosis factor-alpha, and interleukin-10 in patients with acute-on-chronic liver failure associated with hepatitis B virus infection.
    Zou Z; Li B; Xu D; Zhang Z; Zhao JM; Zhou G; Sun Y; Huang L; Fu J; Yang Y; Jin L; Zhang W; Zhao J; Sun Y; Xin S; Wang FS
    J Clin Gastroenterol; 2009 Feb; 43(2):182-90. PubMed ID: 18633332
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phenotypic and functional characterization of intrahepatic T lymphocytes during chronic hepatitis C.
    Leroy V; Vigan I; Mosnier JF; Dufeu-Duchesne T; Pernollet M; Zarski JP; Marche PN; Jouvin-Marche E
    Hepatology; 2003 Oct; 38(4):829-41. PubMed ID: 14512870
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Study of hepatitis C virus specific immune responses in anti-HCV positive patients without hepatitis C viremia.
    Yao P; Hu X; Hu D
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2000 Sep; 14(3):227-30. PubMed ID: 11498684
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis B virus suppresses the functional interaction between natural killer cells and plasmacytoid dendritic cells.
    Shi CC; Tjwa ET; Biesta PJ; Boonstra A; Xie Q; Janssen HL; Woltman AM
    J Viral Hepat; 2012 Feb; 19(2):e26-33. PubMed ID: 22239523
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Upregulation of Fas and downregulation of CD94/NKG2A inhibitory receptors on circulating natural killer cells in patients with new-onset psoriasis.
    Son SW; Kim EO; Ryu ES; Kim TJ; Kim JN; Choi JE; Kye YC; Lee KM
    Br J Dermatol; 2009 Aug; 161(2):281-8. PubMed ID: 19438461
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced B-cell differentiation and reduced proliferative capacity in chronic hepatitis C and chronic hepatitis B virus infections.
    Oliviero B; Cerino A; Varchetta S; Paudice E; Pai S; Ludovisi S; Zaramella M; Michelone G; Pugnale P; Negro F; Barnaba V; Mondelli MU
    J Hepatol; 2011 Jul; 55(1):53-60. PubMed ID: 21145853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 50.